Sign in
THNR Stock Price, Chart, Stats & News
Amplify Weight Loss Drug & Treatment ETF
Save
Amplify Weight Loss Drug & Treatment ETF (THNR) does not currently pay a dividend.
Health
Category
0.59%
Expense ratio
4.14M
Assets
4.19%
1Y return
THNR chart
1M
3M
1Y
5Y
Loading chart...
THNR returns
| YTD | -2.75% |
| 1Y | 4.19% |
| 1Y volatility | 14.33% |
| 3Y volatility | 0.00% |
| Sharpe ratio | 0.00 |
About
The Amplify Weight Loss Drug & Treatment ETF (THNR) offers investors a way to access international firms poised to benefit financially from advancements in weight management pharmaceuticals.
Top 10 THNR holdings
| Holding | Ownership |
|---|---|
Health care 9.78% | |
Health care 9.44% | |
Health care 5.67% | |
Health care 5.53% | |
Health care 5.33% | |
Health care 5.22% | |
Health care 4.99% | |
Health care 4.57% | |
Health care 4.56% | |
Health care 4.53% |
Similar securities
Based on sector and market capitalization
Report issue